5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition

Bioorganic & Medicinal Chemistry Letters
Yves P AubersonMarkus Schmutz

Abstract

NMDA antagonists derived from 5-phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione (3a) are potent anticonvulsant agents, and display strong protective effects in the electroshock-induced convulsion assay in mice. Their preference for the human NMDAR 1A/2A over 1A/2B subunit composition was optimized, leading to (1RS,1'S)-PEAQX (9r), which shows a >100-fold selectivity.

References

Jul 1, 1990·Naunyn-Schmiedeberg's Archives of Pharmacology·M SchmutzH van Riezen
Jan 1, 1982·Journal of Neurochemistry·T HonoréP Krogsgaard-Larsen
Nov 1, 1994·Drugs·W E AulitzkyC Huber
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·Y P AubersonS J Veenstra
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·Y P AubersonS J Veenstra
Feb 18, 1999·Bioorganic & Medicinal Chemistry Letters·Y P AubersonS J Veenstra

❮ Previous
Next ❯

Citations

Oct 29, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Frank HenleDieter K Meyer
Feb 26, 2005·Psychopharmacology·James N C Kew, John A Kemp
May 24, 2011·Molecular Neurobiology·Frank Fetterolf, Kelly A Foster
Apr 23, 2013·Neuroscience Bulletin·Xiao-Min Zhang, Jian-Hong Luo
Oct 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Long-Jun Wu, Min Zhuo
Mar 28, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hsiao-Yun KuKuei-Sen Hsu
Jan 6, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Shuijin HeSuzanne B Bausch
Sep 9, 2010·Proceedings of the National Academy of Sciences of the United States of America·Yuan GeYu Tian Wang
Dec 25, 2008·The Journal of Biological Chemistry·Michael A BeazelyJohn F Macdonald
Dec 4, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Pojeong ParkGraham L Collingridge
Aug 1, 2008·Journal of Neurophysiology·Jacqueline de MarchenaBenjamin D Philpot
May 24, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kenneth R TovarGary L Westbrook
Oct 5, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Shinghua DingPhilip G Haydon
Feb 19, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kelly A FosterMorgan Sheng
Jan 13, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jian YangRoland S G Jones
Feb 11, 2014·Toxicon : Official Journal of the International Society on Toxinology·Randall J PlattBaldomero M Olivera
Jan 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Marcello D'AscenzoPhilip G Haydon
May 30, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Laura Jiménez-SánchezAlbert Adell
Nov 8, 2008·Neural Plasticity·Sophie E L ChamberlainRoland S G Jones
Sep 22, 2009·European Journal of Pharmacology·Mei HuLi-Xin Li
Feb 11, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Yasukazu TerasakiKazuo Kitagawa
Aug 19, 2015·Current Opinion in Structural Biology·Michael C ReganHiro Furukawa
Mar 24, 2009·The European Journal of Neuroscience·Carola RombergOle Paulsen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.